PCSK9 inhibitor (low-dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PCSK9 inhibitor (low-dose), covering 2022-03-28 to 2022-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome [Phase 4]